Response to ranibizumab therapy in neovascular AMD - an evaluation of good and bad responders. (Record no. 19765874)

MARC details
000 -LEADER
fixed length control field 01524 a2200469 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250515221506.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 201005s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1439-3999
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1055/s-0029-1245203
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Menghini, M
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20100524
245 00 - TITLE STATEMENT
Title Response to ranibizumab therapy in neovascular AMD - an evaluation of good and bad responders.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Klinische Monatsblatter fur Augenheilkunde
Date of publication, distribution, etc. Apr 2010
300 ## - PHYSICAL DESCRIPTION
Extent 244-8 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Journal Article
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antibodies, Monoclonal
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antibodies, Monoclonal, Humanized
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Dose-Response Relationship, Drug
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Female
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Macular Degeneration
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Male
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Prevalence
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Prognosis
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Ranibizumab
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Retrospective Studies
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Risk Assessment
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Risk Factors
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Sex Distribution
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Switzerland
General subdivision epidemiology
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Treatment Outcome
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Kurz-Levin, M M
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Amstutz, C
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Michels, S
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Windisch, R
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Barthelmes, D
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Sutter, F Kp
773 0# - HOST ITEM ENTRY
Title Klinische Monatsblatter fur Augenheilkunde
Related parts vol. 227
-- no. 4
-- p. 244-8
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1055/s-0029-1245203">https://doi.org/10.1055/s-0029-1245203</a>
Public note Available from publisher's website

No items available.